St. Paul's Sinus Centre Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04601324
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

St. Paul's Sinus Centre

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4